APA

Leroux-Roels I., Leroux-Roels G., Ofori-Anyinam O., Moris P., De Kock E., Clement F., Dubois M., Koutsoukos M., Demoitié M., Cohen J. & Ballou W. R. (20110209). Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults. : Clinical and vaccine immunology : CVI.

Chicago

Leroux-Roels Isabel, Leroux-Roels Geert, Ofori-Anyinam Opokua, Moris Philippe, De Kock Els, Clement Frédéric, Dubois Marie-Claude, Koutsoukos Marguerite, Demoitié Marie-Ange, Cohen Joe and Ballou W Ripley. 20110209. Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults. : Clinical and vaccine immunology : CVI.

Harvard

Leroux-Roels I., Leroux-Roels G., Ofori-Anyinam O., Moris P., De Kock E., Clement F., Dubois M., Koutsoukos M., Demoitié M., Cohen J. and Ballou W. R. (20110209). Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults. : Clinical and vaccine immunology : CVI.

MLA

Leroux-Roels Isabel, Leroux-Roels Geert, Ofori-Anyinam Opokua, Moris Philippe, De Kock Els, Clement Frédéric, Dubois Marie-Claude, Koutsoukos Marguerite, Demoitié Marie-Ange, Cohen Joe and Ballou W Ripley. Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults. : Clinical and vaccine immunology : CVI. 20110209.